Announcements Trials

Browse Landscape

Phase

Phase 2 4 Phase NA 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 129 Recurrence 27 Precursor Cell Lymphoblastic Leukemia-Lymphoma 23 Neoplasms, Plasma Cell 15 Neoplasms 12 Lymphoma, Non-Hodgkin 12 Lymphoma 12 Leukemia, Myeloid, Acute 10 Lymphoma, Large B-Cell, Diffuse 9 Neoplasm Metastasis 8 Leukemia 8 Burkitt Lymphoma 8 Immunoglobulin Light-chain Amyloidosis 7 Hodgkin Disease 7 Prostatic Neoplasms 6 Leukemia, Biphenotypic, Acute 5 Lymphoma, B-Cell 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Hematologic Neoplasms 4 Waldenstrom Macroglobulinemia 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, T-Cell 3 Lymphoma, Follicular 3 Hematologic Diseases 3 Colorectal Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Sarcoma 2 Rectal Neoplasms 2

Interventions

Cytarabine 11 Cyclophosphamide 10 Filgrastim 9 Etoposide 8 fludarabine phosphate 6 Vorinostat 6 Tacrolimus 6 Peripheral Blood Stem Cell Transplantation 6 Imatinib Mesylate 6 Dasatinib 6 Carboplatin 5 tipifarnib 4 sargramostim 4 Topotecan 4 Sirolimus 4 Bortezomib 4 tanespimycin 3 fludarabine 3 alvocidib 3 Whole-Body Irradiation 3 Sorafenib 3 Flow Cytometry 3 Doxorubicin 3 Decitabine 3 Busulfan 3 Antilymphocyte Serum 3 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 3 laromustine 2 entinostat 2 bryostatin 1 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Blast Crisis × Dexamethasone × Clear all

NCT01204164 2016-05-06

TG02-101

Tragara Pharmaceuticals, Inc.

Phase 1 Completed

Blast Crisis, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡